Overexpression of wild-type presenilin 2 or its familial alzheimer’s disease-associated mutant does not induce or increase susceptibility to apoptosis in different cell lines

[1]  M. Mattson,et al.  Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. , 2008, Journal of neurochemistry.

[2]  M. Mattson,et al.  Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Michaelson,et al.  Increased Expression of Presenilin 2 Inhibits Protein Synthesis , 2002, Molecular and Cellular Neuroscience.

[4]  T. Tabira,et al.  Pro‐apoptotic effect of presenilin 2 (PS2) overexpression is associated with down‐regulation of Bcl‐2 in cultured neurons , 2001, Journal of neurochemistry.

[5]  C. Borner,et al.  Bcl-xS can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-xS to the mitochondria and its BH3 and loop domains , 2001, Cell Death and Differentiation.

[6]  D. Flood,et al.  Presenilin-1 P264L Knock-In Mutation: Differential Effects on Aβ Production, Amyloid Deposition, and Neuronal Vulnerability , 2000, The Journal of Neuroscience.

[7]  T. Tabira,et al.  Overexpression of Presenilin‐2 Enhances Apoptotic Death of Cultured Cortical Neurons , 2000, Annals of the New York Academy of Sciences.

[8]  N. Sonenberg,et al.  Internal ribosome initiation of translation and the control of cell death. , 2000, Trends in genetics : TIG.

[9]  M J Clemens,et al.  Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells , 2000, Cell Death and Differentiation.

[10]  Min Xu,et al.  Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 , 2000, Nature.

[11]  Min Xu,et al.  Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Israeli,et al.  Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Junying Yuan,et al.  Bcl-xS and Bax induce different apoptotic pathways in PC12 cells , 2000, Oncogene.

[14]  Peter Walter,et al.  A Role for Presenilin-1 in Nuclear Accumulation of Ire1 Fragments and Induction of the Mammalian Unfolded Protein Response , 1999, Cell.

[15]  D. Selkoe,et al.  Cell Surface Presenilin-1 Participates in the γ-Secretase-like Proteolysis of Notch* , 1999, The Journal of Biological Chemistry.

[16]  R. Tanzi,et al.  Staurosporine‐Induced Activation of Caspase‐3 Is Potentiated by Presenilin 1 Familial Alzheimer's Disease Mutations in Human Neuroglioma Cells , 1999, Journal of neurochemistry.

[17]  B. Winblad,et al.  Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitiZe SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis , 1999, Neuroscience.

[18]  Y. Itoyama,et al.  Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response , 1999, Nature Cell Biology.

[19]  B. de Strooper,et al.  Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons , 1999, The Journal of cell biology.

[20]  S. Polak‐Charcon,et al.  Impaired Regulation of 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase Degradation in Lovastatin-resistant Cells* , 1999, The Journal of Biological Chemistry.

[21]  I. Kanazawa,et al.  Presenilin 1 Suppresses the Function of C-Jun Homodimers via Interaction with Qm/Jif-1 , 1999, The Journal of cell biology.

[22]  S. Lincoln,et al.  A Loss of Function Mutation of Presenilin-2 Interferes with Amyloid β-Peptide Production and Notch Signaling* , 1999, The Journal of Biological Chemistry.

[23]  Duane D. Miller,et al.  Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease. , 1999, Biochemistry.

[24]  T. Bayer,et al.  Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies , 1999, Journal of neuroscience research.

[25]  D. Selkoe,et al.  Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity , 1999, Nature.

[26]  William J. Ray,et al.  A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain , 1999, Nature.

[27]  C. Haass,et al.  Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Buée,et al.  Mapping the APP/Presenilin (PS) Binding Domains: The Hydrophilic N-Terminus of PS2 Is Sufficient for Interaction with APP and Can Displace APP/PS1 Interaction , 1999, Neurobiology of Disease.

[29]  R. Rozmahel,et al.  Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin,a component of the presenilin protein complex , 1999, Nature Medicine.

[30]  R. Kopito,et al.  Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.

[31]  J. Shioi,et al.  Overexpression in Neurons of Human Presenilin-1 or a Presenilin-1 Familial Alzheimer Disease Mutant Does Not Enhance Apoptosis , 1998, The Journal of Neuroscience.

[32]  K. Roth,et al.  In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system , 1998, Cell Death and Differentiation.

[33]  D. Borchelt,et al.  Effects of PS1 Deficiency on Membrane Protein Trafficking in Neurons , 1998, Neuron.

[34]  J. Buxbaum,et al.  Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment , 1998, Nature Medicine.

[35]  F. Terro,et al.  Characterization of human presenilin 1 transgenic rats: increased sensitivity to apoptosis in primary neuronal cultures , 1998, Neuroscience.

[36]  D. Israeli,et al.  Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression , 1998, Nature Medicine.

[37]  D. Selkoe,et al.  Subcellular Distribution and Turnover of Presenilins in Transfected Cells* , 1998, The Journal of Biological Chemistry.

[38]  R. Stein,et al.  The intracellular domain of p55 tumor necrosis factor receptor induces apoptosis which requires different caspases in naive and neuronal PC12 cells , 1998, Journal of neuroscience research.

[39]  J. Palacino,et al.  Regulation of Apoptosis by Presenilin 1 , 1998, Neurobiology of Aging.

[40]  C. Borner,et al.  Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c , 1998, Nature.

[41]  Hugo Vanderstichele,et al.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.

[42]  M. Mattson,et al.  Presenilins, the Endoplasmic Reticulum, and Neuronal Apoptosis in Alzheimer's Disease , 1998, Journal of neurochemistry.

[43]  T. Ghayur,et al.  Generation of Anti-apoptotic Presenilin-2 Polypeptides by Alternative Transcription, Proteolysis, and Caspase-3 Cleavage* , 1997, The Journal of Biological Chemistry.

[44]  S. Janicki,et al.  Increased Apoptosis Arising from Increased Expression of the Alzheimer's Disease–associated Presenilin-2 Mutation (N141I) , 1997, The Journal of cell biology.

[45]  H. Loetscher,et al.  Presenilins Are Processed by Caspase-type Proteases* , 1997, The Journal of Biological Chemistry.

[46]  R. Tanzi,et al.  Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. , 1997, Science.

[47]  M. Mattson,et al.  Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.

[48]  R. Tanzi,et al.  Endoproteolytic Cleavage and Proteasomal Degradation of Presenilin 2 in Transfected Cells* , 1997, The Journal of Biological Chemistry.

[49]  D. Selkoe,et al.  Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins* , 1997, The Journal of Biological Chemistry.

[50]  T. Iwatsubo,et al.  The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  K. Beyreuther,et al.  Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein , 1997, Nature Medicine.

[52]  P. S. St George-Hyslop,et al.  Phosphorylation, Subcellular Localization, and Membrane Orientation of the Alzheimer's Disease-associated Presenilins* , 1997, The Journal of Biological Chemistry.

[53]  M. Mattson,et al.  Alzheimer's PS‐1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β‐peptide , 1996, Neuroreport.

[54]  T. Sunderland,et al.  Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation , 1996, Science.

[55]  P. Vito,et al.  Requirement of the Familial Alzheimer's Disease Gene PS2 for Apoptosis , 1996, The Journal of Biological Chemistry.

[56]  C. Cotman,et al.  Alzheimer‐associated presenilin‐2 confers increased sensitivity to poptosis in PC12 cells , 1996, FEBS letters.

[57]  D. Selkoe,et al.  The Alzheimer’s Disease-Associated Presenilins Are Differentially Phosphorylated Proteins Located Predominantly within the Endoplasmic Reticulum , 1996, Molecular medicine.

[58]  D. Borchelt,et al.  Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo , 1996, Neuron.

[59]  B. Hyman,et al.  Alzheimer–associated presenilins 1 and 2 : Neuronal expression in brain and localization to intracellular membranes in mammalian cells , 1996, Nature Medicine.

[60]  P. Vito,et al.  Interfering with Apoptosis: Ca2+-Binding Protein ALG-2 and Alzheimer's Disease Gene ALG-3 , 1996, Science.

[61]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[62]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[63]  C. Finch,et al.  Evidence for Apoptotic Cell Death in Alzheimer's Disease , 1995, Experimental Neurology.

[64]  L. Lindenboim,et al.  Inhibition of Drug‐Induced Apoptosis by Survival Factors in PC12 Cells , 1995, Journal of neurochemistry.

[65]  Brian J Cummings,et al.  Immunohistochemical evidence for apoptosis in Alzheimer's disease. , 1994, Neuroreport.

[66]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[67]  J. Lord,et al.  A method for detecting the expression of a toxic gene in cultured cells. , 1991, Analytical biochemistry.

[68]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[69]  Weiming Xia,et al.  Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.